The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration–a phase IV randomised clinical trial with ranibizumab: the FLUID study - Arnold, J J; Markey, C M; Kurstjens, N P (BMC Ophthalmol, 2016)